Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bubblegum-flavored kids’ Zyrtec

This article was originally published in The Tan Sheet

Executive Summary

FDA approves McNeil's proposed label changes and a bubblegum flavor for both Children's Zyrtec formulations, Allergy and Hives Relief (cetirizine 5 mg/5 mL), according to Aug. 14 letters. In addition to the new bubblegum-flavored, sugar-free formulation, the agency approves several manufacturing changes for Children's Zyrtec including the addition of a new manufacturing site for the products, a change in the order of ingredients, adjustment of process temperature and the introduction of a new 2-ounce. bottle size for Children's Zyrtec Allergy syrup. The agency approved Zyrtec for OTC use in November 2007 (1"The Tan Sheet" Nov. 19, 2007, In Brief)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102018

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel